Wed, 12/05/2018 - 15:00

Ten projects have been awarded funding within the JPIAMR 6th transnational call: “Innovations against antibiotic-resistant bacteria: New targets, compounds and tools”. The total funding amount is 12,8 M€. One of the awarded projects:  „Fighting antibiotic-resistant superbugs with anti-persister compounds targeting the stringent response”  will be carried out at the Faculty of Biology of the University of Gdańsk by the research team lead by dr hab. Ewa Laskowska.

The call was launched in January 2018 and supported by 16 research-funding organisations from JPIAMR member countries. 104 applications were received, involving 468 partners.

For any questions concerning the call results, please contact the Joint Call Secretariat:

Agence Nationale de la Recherche
Phone: +33 (0)1 78 09 80 44

The projects awarded funding within the call are:

Acronym project title coordinator Affiliation countries
ANTIBIO-LAB Anti-Biofilm therapies using Local Application of bacteriophages Fintan Moriarty AO Research Institute Davos Belgium, Switzerland, Germany
Anti-Persistence Fighting antibiotic-resistant superbugs with anti-persister compounds targeting the stringent response Abel Garcia-Pino Université Libre de Bruxelles Belgium, France, Spain, Poland
CRISPRattacK Advancing CRISPR antimicrobials to combat the bacterial pathogen Klebsiella pneumoniae Chase Beisel Helmholtz Center for Infection Research Israel, France, Germany
DISRUPT Fighting antimicrobial resistant infections by high-throughput discovery of biofilm-disrupting agents and mechanisms Morten Kjos Norwegian University of Life Sciences Norway, Germany, Switzerland
Explore Exploration of the TPP riboswitch as a new target for antibiotics Ruth Brenk University of Bergen Canada, Czech Republic, Latvia, Germany, Norway
FLAV4AMR Flavodoxin inhibitors to kill resistant bacteria Javier Sancho University of Zaragoza France, Germany, Spain
MTI4MDR-TB Development of novel Mycobacterial Tolerance Inhibitors (MTIs) against MDR/XDR tuberculosis Fredrik Almqvist Umeå University France, Norway, Spain, Sweden, USA
RESET-ME Restoring E. coli Sensitivity for Antibiotics by blocking TolC-Mediated Efflux Björn Windshügel Fraunhofer Institute for Molecular Biology and Applied Ecology IME Finland, Germany, Italy, Latvia
RIBOTARGET Development of Novel Ribosome-targeting Antibiotics Daniel Wilson University of Hamburg Germany, Czech Republic, France, Sweden, Switzerland, Italy
SCAN Design, Synthesis and Lead Generation of Novel Siderophore Conjugates for the Detection and Treatment of Infections by Gram-Negative Pathogens Mark Brönstrup Helmholtz Centre for Infection Research France, Germany, Israel